Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

54.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
54.7K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.2K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.2K
Cloning of Dolly the Sheep01:08

Cloning of Dolly the Sheep

6.0K
The first successfully cloned mammal was Dolly, a sheep, born on 5th July 1996 at Roslin Institute, Scotland. The cloned sheep was named after the American singer Dolly Parton. Dolly lived for seven years and died of respiratory complications, which is speculated to be due to the actual age of her DNA. Because the DNA in cloned cells belongs to an older individual,  the cloned individual’s life expectancy may be affected. Indeed, analysis of Dolly’s DNA revealed shorter...
6.0K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.0K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.0K
Reproductive Cloning01:27

Reproductive Cloning

31.8K
Reproductive cloning is the process of producing a genetically identical copy—a clone—of an entire organism. While clones can be produced by splitting an early embryo—similar to what happens naturally with identical twins—cloning of adult animals is usually done by a process called somatic cell nuclear transfer (SCNT).
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic...
31.8K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.4K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.

Acta dermato-venereologica·2026
Same author

Precision medicine 'versus' or 'for' public health? Different configurations of precision medicine in relation to the social determinants of health.

Social science & medicine (1982)·2026
Same author

Unlock AI model sharing for EU health data.

Science (New York, N.Y.)·2026
Same author

Editors' Note.

Narrative inquiry in bioethics·2026
Same author

Synthetic biology's uncertain regulatory future in the wake of Loper Bright Enterprises v. Raimondo.

Nature biotechnology·2026
Same author

The role of gene-environment interactions in endocrine-sensitive life stages for shaping mental health: focus on the RE-MEND project.

Frontiers in psychiatry·2026
Same journal

Harm Reduction as an Alternative to Mandated Drug Treatment.

The Hastings Center report·2026
Same journal

Rethinking Mandated Drug Treatment: Why Expanding Freedom Requires Structural Drug Policy Reform.

The Hastings Center report·2026
Same journal

Banning Gender-Affirming Treatment for Minors: The Supreme Court Speaks.

The Hastings Center report·2026
Same journal

Making the Move to a Learning System of Research Ethics.

The Hastings Center report·2026
Same journal

Musical Performance and Biomedical Human Enhancement: Ethnographic Perspectives on Bioethical Questions.

The Hastings Center report·2026
Same journal

Transformed but Not Cured: The Ethics of Describing Gene-Editing Therapy for Sickle Cell Disease.

The Hastings Center report·2026
See all related articles

Related Experiment Video

Updated: Nov 16, 2025

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation
12:09

Protocol for Human Blastoids Modeling Blastocyst Development and Implantation

Published on: August 10, 2022

7.0K

Rethinking Human Embryo Research Policies.

Kirstin R W Matthews, Ana S Iltis, Nuria Gallego Marquez

    The Hastings Center Report
    |February 25, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Technological advances now permit culturing human embryos beyond 14 days, raising ethical questions about the established limit. Reassessing this limit requires stakeholder engagement and enhanced oversight for human embryo research.

    Keywords:
    embryofourteen-day limitguidelinespolicyresearch ethics

    More Related Videos

    Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis
    12:32

    Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis

    Published on: September 7, 2021

    2.4K
    Human Blastocyst Biopsy and Vitrification
    10:59

    Human Blastocyst Biopsy and Vitrification

    Published on: July 26, 2019

    23.1K

    Related Experiment Videos

    Last Updated: Nov 16, 2025

    Protocol for Human Blastoids Modeling Blastocyst Development and Implantation
    12:09

    Protocol for Human Blastoids Modeling Blastocyst Development and Implantation

    Published on: August 10, 2022

    7.0K
    Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis
    12:32

    Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis

    Published on: September 7, 2021

    2.4K
    Human Blastocyst Biopsy and Vitrification
    10:59

    Human Blastocyst Biopsy and Vitrification

    Published on: July 26, 2019

    23.1K

    Area of Science:

    • Developmental biology
    • Bioethics
    • Reproductive medicine

    Background:

    • The 14-day limit for human embryo culture, once a compromise, is now an ethical consideration.
    • Technological advancements enable embryo culture beyond this traditional limit.

    Purpose of the Study:

    • To evaluate the continued relevance of the 14-day limit for human embryo culture.
    • To explore potential modifications to the limit and the justifications required.
    • To consider the ethical implications and stakeholder perspectives on extending embryo research.

    Main Methods:

    • Ethical analysis of the 14-day rule in human embryo research.
    • Review of technological capabilities in embryo culture.
    • Examination of stakeholder engagement processes.

    Main Results:

    • Technical feasibility of culturing human embryos beyond 14 days is established.
    • The 14-day limit's ethical relevance is questioned due to scientific progress.
    • Need for reassessment of the limit, considering moral objections and scientific understanding.

    Conclusions:

    • The 14-day limit for human embryo culture may need reevaluation in light of new technologies.
    • Stakeholder engagement and robust oversight systems are crucial for ethical advancement in human embryo research.
    • Developing reliable oversight can foster high-quality research and public trust.